THE Brunei Cancer Centre (BCC) organised a multi-disciplinary symposium on February 15 in conjunction with the recent World Cancer Day for health professionals as part of the yearly CME activities (Continuing Medical Education). It was held at The Rizqun Hotel and was attended by about 150 participants including medical specialist doctors, nursing staff and allied health.
The aim of the symposium was to increase awareness about prostate cancer, for earlier detection; modalities of imaging; newer modalities of treatment, including surgery, radiotherapy, hormonal, newer targeted therapies and chemotherapy; and importance of multi-disciplinary approach.
Prostate cancer is one of the commonest cancers in older men above the age of 50 and is the commonest cancer in many developed countries. Screening programmes in many developed countries, have been picking up cases at early stages.
But in many countries, including Brunei Darussalam, the diagnosis is missed and diagnosed in advanced metastatic stage.
The speakers for the symposium were: Prof Dr Marniza bte Saat, Clinical Oncologist, University Malaya Medical Centre; Dr Adlinda, Lecturer, Clinical Oncologist, University Malaya Medical Centre; Hajah Zuraini binti Haji Ibrahim, Specialist Urologist, RIPAS Hospital; Pengiran Haji Md Bahrin bin Pengiran Haji Alliudin, Pathologist, RIPAS Hospital; Dr Ravi Patnaik, Specialist Oncologist; TBCC Chairpersons Dato Dr Babu Sukumaran, Dr Shamir Chandran, Norzehan binti Saini and Case discussants Dr Harimohan and Dr Samer.
The event was attended by health professionals from the different government hospitals in the districts and from private clinics. It was co-sponsored by pharmaceutical company Johnson & Johnson.